BioWorld

Jan. 28, 2005

View Archived Issues

Amgen Reports Higher Revenues, Sales; Earnings Below Estimates

Despite experiencing a 24 percent increase in product sales and a 26 percent increase in adjusted earning, Amgen Inc. missed its earning expectations for the fourth quarter. (BioWorld Today) Read More

Ariad, Stent Company Medinol In Partnership Worth Up To $40M

Read More

Theravance Begins Second Phase III Trial For Telavancin

Read More

Zonagen Brings In $17.6M To Push Progenta, Androxal Work

Read More

Other News To Note

Read More